Ciprofloxacin hydrochloride 99%

Ciprofloxacin hydrochloride is suitable for urinary tract infection, moderate and severe respiratory tract infection, intestinal infection, skin and soft tissue infection, sepsis and intraperitoneal infection caused by sensitive bacteria.

This product is one of the excellent representatives of quinolone antibiotics. It was successfully developed by Bayer pharmaceutical company in Germany in 1983. The first generation of quinolone antibiotics is represented by naphthyridic acid, the second generation is represented by Pipemidic Acid, and the third generation is represented by norfloxacin. Ciprofloxacin has a wide antibacterial spectrum and strong antibacterial activity. It is effective for Gram-positive bacteria and Gram-negative bacteria, as well as Pseudomonas aeruginosa, with less adverse reactions. It is a drug variety with large sales in the international market.